Sign in
4

Changes in Ownership

Theriva Biologics, Inc. Filed Acc 0001104659-19-070376

Options or other derivatives

  • Director acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tarriff Scott · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-04 Grant or award : show line 1 in the form Stock Options +250,000 250,000 D
Loading xslF345X03/tm1923941d5_form4.xml…